INTRODUCTION
compared with JNK and p38 MAPK (31) . On the contrary, ROS and hyperosmolar stress are potent stimuli for JNK and p38 MAPK in fibroblasts and ECs (21) . However, in rat vascular smooth muscle cells, ROS stimulated big MAPK1, but not ERK1/2 (14) . Thus, the specificity of activation of different classes of MAPKs by individual stimulus is dictated by specific agonist for each group of the kinase. One common substrate for the MAPKs is transcriptional factors such as nuclear factor kappa B and AP1, which may induce specific gene expression (12, 13, 20, 34) .
In endothelium, ROS, such as hydrogen peroxide (H 2 O 2 ) and diperoxovanadate, activate ERK1/2, JNK, and p38 MAPK (18, 22) . The stress-induced stimulation of MAPKs is regulated by intracellular glutathione (GSH)/oxidized glutathione (GSSG) levels, suggesting a role for redox status in modulating MAPK activity (11, 12, 33) . As ROS alter EC permeability to macromolecules, we hypothesized that redox changes in ECs regulate ROS-dependent MAPK activation and barrier dysfunction. Here we show that H 2 O 2 -induced barrier dysfunction in bovine lung microvascular ECs (BLMVECs) is dependent on p38 MAPK, but not ERK1/2. Furthermore, a decrease in intracellular levels of GSH induced by either H 2 O 2 or diamide regulates p38 MAPK activation and EC barrier function. These alterations by intracellular redox imbalance were blocked by pretreatment of the cells with N-acetylcysteine (NAC).
MATERIALS AND METHODS

Reagents
BLMVECs were purchased from Clonetics (San Diego, CA, U.S.A.). H 2 O 2 , NAC, diamide, EC growth factor, minimum essential medium (MEM), fetal bovine serum, and nonessential amino acids were obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.). PD98059 and SB203580 were purchased from Calbiochem (La Jolla, CA, U.S.A.). Polyclonal ERK1/2, p38 MAPK, phospho-specific ERK1/2, and p38 MAPK antibodies were procured from Cell Signaling (Boston, MA, U.S.A.). Secondary anti-rabbit or antimouse Ig (H+L) horseradish peroxidase conjugates were obtained from Bio-Rad (Hercules, CA, U.S.A.). Enhanced chemiluminescence kit was from Amersham (Arlington Heights, IL, U.S.A.). Polyvinylidene difluoride immobilon-P transfer membrane was purchased from Millipore, U.K.
Cell culture
BLMVECs were cultured in MEM supplemented with 10% fetal bovine serum, antibiotics, and growth factors as described previously (28) . Confluent cells in T-75 cm 2 flasks were trypsinized and subcultured in 35-mm dishes; the cells showed cobblestone morphology and stained positive for factor VIII-related antigen. All experiments were carried out between 5 and 9 passages.
Measurement of EC permeability by albumin flux
Albumin permeability across EC monolayers was performed as previously described (30) . In brief, the system consisted of two compartments, upper (luminal) and lower (abluminal), which were separated by a polycarbonate microporemembrane filter (Nuclepore, Pleasanton, CA, U.S.A.). Medium 199 with 25 mM HEPES was used in both compartments. BLMVECs grown on polycarbonate membranes were pretreated for 1 h with PD98059 (25 µM) or SB203580 (25 µM) followed by addition of H 2 O 2 (100 µM). Clearance of albumin (4% final concentration) coupled to Evans blue dye across cell monolayers was determined for 2 h. Transendothelial cell albumin transport was determined by measuring the absorbance of Evans blue dye in abluminal chamber samples at 620 nm in a spectrophotometer (Vmax Multiplate Reader, Molecular Devices, Menlo Park, CA, U.S.A.).
Measurement of transendothelial electrical resistance (TER) as an index of barrier dysfunction
BLMVECs were seeded on gelatin-coated gold electrodes (eight wells, one electrode per well) to ~95% confluence as described earlier (30) . Electrodes were placed into an electrical cell-substrate impedance sensing system (ECIS; Applied Biophysics Inc., Troy, NY, U.S.A.) incubator for 1 h to stabilize basal electrical resistance before pretreatment with NAC or MAPK inhibitors or H 2 O 2 as indicated. The total endothelial electrical resistance, as measured across the EC monolayers, was determined by the combined resistance between the basal and/or cell matrix adhesion (8, 9) . Measurements were done in triplicate and expressed as normalized resistance (means ± SD) for each of the treatments.
Quantification of endothelial GSH and GSSG
BLMVEC GSH and GSSG levels were determined by earlier published procedures using sulfosalicylic acid-dependent color reaction with GSH in cell lysates (24) . Absorbance at 412 nm against appropriate blanks was carried out on a Beckman DU-650 spectrophotometer.
Modulation of intracellular GSH
Lung microvascular EC GSH levels were modified by treating with thiol-depleting or thiol-generating agents. Diamide, a potent cell-permeable oxidizing agent, preferentially oxidizes low-molecular-weight free thiols (GSH) and protein-SH groups and induces formation of disulfide bonds and disulfide cross-links in proteins (24) , whereas buthionine sulfoximine (BSO) is a specific and irreversible inhibitor of g-glutamylcysteine synthase. These inhibitors cause a marked decrease in total intracellular GSH pool by different action. NAC, on the contrary, provides cysteine to cells, thereby enhancing intracellular GSH (4, 38) . Thiol depletion in BLMVECs was carried out by exposing cells to varying concentrations of diamide for 1 or 2 h. Cells were treated with NAC (5 mM) for 1 h and washed with MEM before exposure to H 2 O 2 .
Treatment of cells with agents, preparation of cell lysates, and western blotting
BLMVECs grown on 100-mm dishes to ~95% confluence were pretreated with NAC, diamide, or MAPK inhibitors in 724 USATYUK ET AL.
MEM for specified time periods, as indicated before stimulation with H 2 O 2 or other agents. The cells were washed once in ice-cold phosphate-buffered saline containing 1 mM orthovanadate, scraped into 0.5 ml of lysis buffer (20 mM Tris-HCl buffer, pH 7.4, containing 0.5% deoxycholate, 0.5% sodium dodecyl sulfate (SDS), 1% Triton X-100, 1% Nonidet P-40, 1 mM sodium orthovanadate, and protease inhibitor cocktail). The samples were sonicated three times for 15 s each with a probe sonicator and centrifuged at 5,000 g for 5 min at 4°C. An aliquot of the supernatant was used for total protein determination by the BCA protein assay (Pierce Chemicals). Another aliquot of the supernatant was mixed with 63 Laemmli buffer to give a final protein concentration of 1 µg/µl and was subjected to SDS-polyacrylamide gel electrophoresis (PAGE) on 10% gels. After SDS-PAGE, the proteins were transferred to Immobilon-P membranes by electroblotting, blocked for 1 h with TBST (Tris-buffered saline with 0.1% Tween 20) containing 5% bovine serum albumin and incubated for 18-24 h at 4°C with either ERK1/2 (1:2,000 dilution), p38 MAPK (1:3,000 dilution), phospho-ERK1/2 or phospho-p38 MAPK (1:1,000 dilution), or phospho-ATF-2 (ATF-2, activating transcription factor-2) (1:1,000 dilution) antibodies. The membranes were washed at least three times with TBST, followed by incubation with anti-rabbit or anti-mouse IgG conjugated to horseradish peroxidase (1:2,000 dilution) for 2-4 h at room temperature, and the blots were developed with enhanced chemiluminescence. Densitometry of the blots was carried out with a scanner and quantified by Image analyzer.
Statistical analysis
All values are expressed as means ± SD from triplicate samples and three independent experiments. Data were subjected to one-way ANOVA, and pairwise multiple comparisons were done by Dunnett's method. A p value of <0.05 was considered significant.
RESULTS
H 2 O 2 decreases TER
Measurement of TER generated across EC monolayers under normal and stimulated conditions serves as a reliable and sensitive method to determine barrier function (8, 9) . To determine the effect of H 2 O 2 on barrier function, BLMVECs grown on gold electrodes were stimulated with varying concentrations of H 2 O 2 , which decreased TER in a dosedependent fashion (vehicle, resistance normalized to 1; 25 µM H 2 O 2 , 0.88 ± 0.2; 50 µM H 2 O 2 , 0.64 ± 0.19; 100 µM H 2 O 2 , 0.51 ± 0.29 after 1 h of treatment) (Fig. 1 ). At lower doses of H 2 O 2 , the decrease in TER was partially reversible with prolonged time periods (Fig. 1 ). These results show that H 2 O 2 , in a dose-and time-dependent fashion, causes barrier dysfunction in lung microvascular EC monolayers.
Redox imbalance contributes to H 2 O 2 -induced barrier dysfunction
As ROS alter redox status of ECs (19, 32, 33, 38) , we investigated the role of cellular GSH on barrier dysfunction. (Fig. 2) . To determine the relative contribution of cellular GSH levels on barrier function, BLMVECs were pretreated with 5 mM NAC before exposure to H 2 O 2 . As shown in Fig. 3 , NAC prevented the H 2 O 2 -induced changes in TER in a time-dependent manner. These data suggest a role for cellular GSH in regulating ROS-mediated barrier dysfunction in ECs.
Depletion of intracellular GSH by diamide causes EC barrier dysfunction
To establish further a direct correlation between changes in cellular GSH and barrier dysfunction, we evaluated the effect of diamide, an agent that oxidizes GSH to GSSG and -SH (Fig. 4) . Pretreating the cells with NAC (5 mM) for 1 h elevated GSH levels in both control and diamide-challenged cells by 2.5-fold and 1.8-fold, respectively, compared with cells not treated with NAC (NAC, 9.5 ± 0.3 µg/mg of protein; NAC + diamide, 6.9 ± 0.2 µg/mg of protein) (Fig. 4) . Next we investigated the effect of diamide and NAC plus diamide on EC barrier function. Diamide (25-100 µM) treatment of BLMVECs decreased TER, an index of monolayer permeability (Fig. 5 ). This effect of diamide on TER was partially prevented by pretreatment of cells with NAC (5 mM), which elevated intracellular GSH content (Fig. 4 ). These results demonstrate that depletion of cellular GSH by a chemical agent such as diamide resulted in EC barrier dysfunction similar to that of H 2 O 2, which was reversed by NAC, suggesting redox regulation of permeability changes in microvascular ECs.
H 2 O 2 and diamide activate ERK and p38 MAPK in microvascular ECs
To investigate signal transduction pathways regulating barrier dysfunction, BLMVECs were treated with H 2 O 2 or diamide, and total cell lysates were analyzed by western blotting for phosphorylation of ERK and p38 MAPK with phospho-specific antibodies. As shown in Fig. 6 , both H 2 O 2 and diamide, in a dose-dependent manner, enhanced phosphorylation of threonine/tyrosine residues of ERK1/2 and p38 MAPK.
H 2 O 2 -and diamide-induced barrier dysfunction requires p38 MAPK activation
To elucidate further the role of MAPKs in mediating H 2 O 2 -and diamide-induced barrier dysfunction, we used selective and known pharmacological inhibitors of ERK1/2 and p38 MAPK. As shown in Fig. 7 , pretreatment of BLMVECs with PD98059 (25 µM), a specific inhibitor of MEK1/2 (6), did not affect H 2 O 2 -induced increase in albumin flux. In contrast, pretreatment of ECs with SB203580 (25 µM), a selective blocker of p38 MAPK (17), partially prevented H 2 O 2 -or diamide-induced permeability changes as measured by enhanced albumin flux across the ECs (Fig. 7) or TER (Fig. 8) . The effect of SB203580 on H 2 O 2 -or diamide-induced barrier dysfunction was time-dependent (Fig. 8) . In parallel experiments, the effect on SB203580 on H 2 O 2 -or diamide-induced p38 MAPK activation was examined. As shown in Fig. 9 , SB203580 attenuated p38 MAPK activity as determined by phosphorylation of ATF-2 and had no effect phosphorylation of p38 MAPK because SB203580 directly binds to p38 MAPK and alters its kinase activity (17) . These data suggest that p38 MAPK activation is part of the signaling cascade involved in H 2 O 2 -or diamide-induced barrier dysfunction.
NAC attenuates H 2 O 2 -and diamide-induced p38 MAPK activation
To determine further if activation of p38 MAPK is under redox regulation in lung microvascular ECs, we studied the 726 USATYUK ET AL.
FIG. 3. NAC attenuates H 2 O 2 -induced endothelial barrier dysfunction.
BLMVECs grown on gold microelectrodes tõ 95% confluence were pretreated with NAC (5 mM) for 1 h and then challenged with H 2 O 2 (100 µM), and TER was measured as described in Materials and Methods. Shown is a representative tracing from three independent experiments in duplicate.
FIG. 4. NAC prevents diamide-induced reduction in cellular GSH.
BLMVECs were pretreated with NAC (5 mM) for 1 h and then challenged with diamide (100 µM) for 1 h. GSH level in cell lysates was determined as described in Materials and Methods. n = 3. *Significantly different from vehicle (p < 0.05); **significantly different from NAC treatment (p < 0.05).
FIG. 5. NAC attenuates diamide-induced endothelial barrier dysfunction.
BLMVECs grown on gold microelectrodes to ~95% confluence were pretreated with NAC (5 mM) for 1 h and then were challenged with diamide (100 µM), and TER was measured as described in Materials and Methods. Shown is a representative tracing from three independent experiments in duplicate. effect of NAC on H 2 O 2 -and diamide-induced MAPK phosphorylation. As shown in Fig. 10 , pretreatment of BLMVECs with NAC (5 mM) for 1 h attenuated the H 2 O 2 -or diamideinduced p38 MAPK phosphorylation and ATF-2 phosphorylation. These results indicate that NAC negatively regulated p38 MAPK activation by H 2 O 2 or diamide by increasing intracellular levels of GSH.
DISCUSSION
In the present study, we examined signal transduction pathways that regulate barrier dysfunction by ROS in lung microvascular ECs. The results show that (a) H 2 O 2 -induced EC barrier dysfunction is dependent on depletion of intracellular GSH levels; (b) H 2 O 2 -induced barrier dysfunction is regulated by the p38 MAPK signaling pathway; (c) diamide, an agent that oxidizes GSH, also altered EC permeability via p38 MAPK; and (d) NAC prevented H 2 O 2 -and diamideinduced p38 MAPK activation and barrier dysfunction. These results indicate that redox regulation by intracellular GSH plays a crucial role in ROS-mediated activation of MAPK and barrier dysfunction in lung microvascular ECs.
The mechanisms of ROS-induced permeability changes in ECs have not been completely defined. Earlier studies suggest that ROS-mediated permeability changes in ECs involve increase of intracellular calcium, activation of protein kinase C, Src kinase, and myosin light chain kinase (5, 11, 30, 33, 35) . A novel finding of the present study is the role of p38 MAPK activation regulating ROS-induced barrier dysfunction in lung microvascular ECs. Furthermore, NAC pretreatment blocked p38 MAPK, but not ERK1/2 phosphorylation and barrier dysfunction, implicating redox regulation of p38 MAPK and endothelial permeability changes by intracellular GSH levels modulated by oxidative stress. p38 MAPK belongs to a subfamily of mammalian MAPKs that also includes ERK1/2, JNK/stress-activated protein kinases, and ERK5. Activation of p38 MAPK by stimuli is mediated by phosphorylation of threonine/tyrosine residues catalyzed by distinct and dual specific serine/threonine MAPKs (MKK3, MKK4, and MMK6), which in turn are phosphorylated by upstream MKK kinases (3). Our study is consistent with the earlier reports that showed a link between depletion of cellular GSH, modulation of MAPKs, and altered cytokine expression and secretion (26) . Tumor necrosis factor-a induced p38 MAPK activation, and p38 MAPK-mediated interleukin-8 secretion in human pulmonary vascular ECs was attenuated by NAC, indicating redox regulation of the tumor necrosis factor-a effect (27) . Similarly, thiol depletion in lung fibroblasts induced oxidant accumulation and apoptosis (1) . Thiol depletion in lung fibroblasts also induced leukotriene synthesis and p38 MAPK phosphorylation, which were essential for induction of apoptosis (1) . We have demonstrated earlier a role for intracellular thiols in ROS-induced phospholipase D (PLD) activation in bovine pulmonary artery ECs, which was confirmed by depletion of intracellular GSH by diamide and BSO. In these studies, NAC not only reversed ROS-induced PLD activation, but also attenuated diamide-mediated PLD stimulation and tyrosine phosphorylation of proteins (24) . The ability of NAC to inhibit different MAPKs is varied. In rat cardiac fibroblasts, NAC and nitric oxide blocked angiotensin II-mediated activation of ERK1/2, consistent with redox regulation of ERK (36) . In the present study, although H 2 O 2 and diamide enhanced phosphorylation of ERK1/2, and p38 MAPK, pretreatment of BLMVECs with NAC blocked p38 MAPK, but not ERK 1/2, with both treatments. These results further suggest that in BLMVECs the MAPKs are differently regulated by redox status of the cell. How p38 activation by ROS regulates endothelial barrier function is unclear. Possible mechanism(s) include the involvement of heat shock protein (HSP) 27, cytoskeleton, focal adhesion plaques, and adherens junction proteins. HSP 27 is closely associated with the regulation of actin polymerization (15) . Phosphorylation of HSP 27 is mediated by the mitogenactivated protein kinase-activated protein kinase-2 (MAP-KAPK-2), an immediate downstream target of p38 MAPK (23) . As ROS-mediated activation of p38 MAPK involves MKK3/6 and MAPK phosphatases-1 (2), it should be of interest to determine which of these enzymes is redox-regulated. In addition to HSP 27, p38 MAPK may be involved in phosphorylation of caveolin-1 at tyrosine 14 residues via Src kinase. Phosphorylation of caveolin-1 is known to regulate changes in cell shape and reorganization of cytoskeleton (16) . Focal adhesions are major cellular sites of nonreceptor tyrosine kinase-mediated signal transduction, and as phospho-caveolin-1 is localized in close proximity to focal adhesions, the signaling pathway of p38 MAPK ® cSrc ® phospho-cave-
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USATYUK ET AL. olin-1 in part may be involved in ROS-induced cell shape, cytoskeletal reorganization, and barrier disruption. Experiments are currently under way to elucidate further the mechanism(s) of p38 MAPK in ROS-induced reorganization of actin cytoskeleton and barrier dysfunction. In summary, we have shown that H 2 O 2 treatment of lung microvascular ECs results in the activation of p38 MAPK and permeability changes as measured by transendothelial resistance measurement. Increased phosphorylation of p38 MAPK and barrier dysfunction by H 2 O 2 were prevented by pretreatment of cells with NAC, an agent that modulates intracellular levels of GSH and cellular thiols. Furthermore, diamide mimicked the action of H 2 O 2 in reducing intracellular GSH, increasing p38 MAPK phosphorylation, and decreasing endothelial electrical resistance, demonstrating an important role for redox regulation of barrier function in the endothelium.
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